Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Bristol, North Somerset and South Gloucestershire ICB ("the Commissioner") sought to commission the block provision of Pathway 3 (P3) Discharge to Assess Community Beds for patients in BNSSG. These beds will be delivered at Rose Garden and Olive Tree House in South Gloucestershire, operated by Allegra Care Group.
BNSSG ICB has implemented a Discharge to Assess model following hospital admission, in collaboration with ICS partners. The vision of the model is to maximise independence, de‑escalate care as early as possible, and prevent de‑compensation. Over time this is expected to increase the number of people managing independently or with appropriate support at home and reduce reliance on bed‑based care in both the short and long term.
BNSSG ICB has followed PSR Direct Award Process C for the contract to which this notice relates.
The service is VAT‑exempt, and all contract values stated are excluding VAT
This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Allegra Services Limited | 14156358 | £1,370,651 | 1 lot Lot 1 | CH MISMATCH CF says 14156358, but CH says it's MREF V CARE HOLDINGS LIMITED |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £1,370,651 initial term | 1 single bid — no competition | active |
Weightings from the notice.
Changes the buyer published to this notice after it first appeared.
The contract period commenced on 1st April 2026 for an initial 18-month contract and an optional 12-month extension.
The total expected value of the contract for the initial 18-month contract term is £821,781.95 excluding VAT The optional 12-month extension expected value of the contract is £548,869.31 excluding VAT. Therefore, the full expected lifetime contract value (18-month + optional 12-month extension) is £ 1,370,651.25 excluding VAT.
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and The Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C.